ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Coloplast AS

Coloplast AS (CBHD)

108.70
-1.15
(-1.05%)
Closed January 25 4:00PM
Realtime Data

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
108.70
Bid
108.60
Ask
108.65
Volume
1,169
108.00 Day's Range 110.00
102.75 52 Week Range 131.15
Market Cap
Previous Close
109.85
Open
110.00
Last Trade
3
@
108.75
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,656
Shares Outstanding
210,200,000
Dividend Yield
68.61%
PE Ratio
4.63
Earnings Per Share (EPS)
24.03
Revenue
27.03B
Net Profit
5.05B

About Coloplast AS

Sector
Ortho,prosth,surg Appl,suply
Industry
Health Care Diversified
Headquarters
Humlebaek, Dnk
Founded
1990
Coloplast AS is listed in the Ortho,prosth,surg Appl,suply sector of the Tradegate (DE) with ticker CBHD. The last closing price for Coloplast AS was 109.85 €. Over the last year, Coloplast AS shares have traded in a share price range of 102.75 € to 131.15 €.

Coloplast AS currently has 210,200,000 shares outstanding. The market capitalization of Coloplast AS is 23.09 € billion. Coloplast AS has a price to earnings ratio (PE ratio) of 4.63.

CBHD Latest News

Coloplast A/S - Q1 2024/25 Earnings Release - Invitation to conference call on 4 February 2025 at 11.00am CET (correction)

Coloplast A/S - Q1 2024/25 Earnings Release - Invitation to conference call on 4 February 2025 at 11.00am CET (correction) Tuesday, 4 February 2025 at 11.00 - 12.00am CET (corrected from 10.00...

Coloplast A/S - Q1 2024/25 Earnings Release - Invitation to conference call on 4 February 2025 at 11.00am CET

Coloplast A/S - Q1 2024/25 Earnings Release - Invitation to conference call on 4 February 2025 at 11.00am CET Tuesday, 4 February 2025 at 10.00 - 11.00am CETIn connection with the publication of...

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons Please see enclosed pdf.   Attachment 11122024_trading_in_shares_GL

Coloplast A/S - Decisions at the Annual General Meeting 2024

Coloplast A/S - Decisions at the Annual General Meeting 2024 Today, 5 December 2024, Coloplast A/S held its Annual General Meeting, at which the following resolutions were adopted: The annual...

Coloplast divests core Skin Care product portfolio

Coloplast divests core Skin Care product portfolio The divestment is part of a strategic initiative to simplify business operations and improve profitability in the Advanced Wound Care business...

Kerecis included on the list of covered products for Diabetic Foot Ulcers in the final LCD policy

Kerecis included on the list of covered products for Diabetic Foot Ulcers in the final LCD policy On 14 November 2024, the U.S. Centers for Medicare & Medicaid Services (CMS) issued a final...

Coloplast A/S - Notice of Annual General Meeting 2024

Coloplast A/S - Notice of Annual General Meeting 2024 The Annual General Meeting of Coloplast A/S will be held onThursday, 5 December 2024 at 3:30 pm CETat the premises of Coloplast A/S, Holtedam...

Coloplast A/S - Annual Report 2023/24 & Remuneration Report 2023/24

Coloplast A/S - Annual Report 2023/24 & Remuneration Report 2023/24 Coloplast A/S - Annual Report 2023/24 & Remuneration Report 2023/24 FY 2023/24 organic growth of 8% and 27% EBIT...

Coloplast A/S - Full-Year Financial Results 2023/24

Coloplast A/S - Full-Year Financial Results 2023/24 2023/24 Announcement of full-year financial results 1 October 2023 - 30 September 2024 Coloplast delivered Q4 organic growth of 8% and an EBIT...

Coloplast A/S - Announcement no. 05/2024 - Coloplast expands Executive Leadership Team

Coloplast A/S - Announcement no. 05/2024 - Coloplast expands Executive Leadership Team Coloplast expands Executive Leadership Team Today, the Board of Directors have decided to expand the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
121.87441424555106.7112.25106.71453109.17222987DE
42.252.11366838891106.45112.25103.31488106.61775368DE
12-6.4-5.56038227628115.1125.45103.31656113.1169846DE
26-9.45-7.99830723656118.15128.5103.31321116.24272915DE
523.53.32699619772105.2131.15102.751634116.86467354DE
156-20.8-16.0617760618129.515092.541033111.77581006DE
260-5.85-5.10694020079114.55160.692.54764115.84980949DE

CBHD - Frequently Asked Questions (FAQ)

What is the current Coloplast AS share price?
The current share price of Coloplast AS is 108.70 €
How many Coloplast AS shares are in issue?
Coloplast AS has 210,200,000 shares in issue
What is the market cap of Coloplast AS?
The market capitalisation of Coloplast AS is EUR 23.09B
What is the 1 year trading range for Coloplast AS share price?
Coloplast AS has traded in the range of 102.75 € to 131.15 € during the past year
What is the PE ratio of Coloplast AS?
The price to earnings ratio of Coloplast AS is 4.63
What is the cash to sales ratio of Coloplast AS?
The cash to sales ratio of Coloplast AS is 0.87
What is the reporting currency for Coloplast AS?
Coloplast AS reports financial results in DKK
What is the latest annual turnover for Coloplast AS?
The latest annual turnover of Coloplast AS is DKK 27.03B
What is the latest annual profit for Coloplast AS?
The latest annual profit of Coloplast AS is DKK 5.05B
What is the registered address of Coloplast AS?
The registered address for Coloplast AS is HOLTEDAM 1-3, HUMLEBAEK, DK-3050
What is the Coloplast AS website address?
The website address for Coloplast AS is www.coloplast.com
Which industry sector does Coloplast AS operate in?
Coloplast AS operates in the HEALTH CARE DIVERSIFIED sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LL3PanGenomic Health Inc
0.2999 €
(67.26%)
2.89k
VAR1Varta AG
1.00 €
(37.93%)
3.62M
FP9Five Point Holdings LLC
5.35 €
(36.48%)
20
UD9Mason Resources Inc
0.0616 €
(36.28%)
28k
8CTCannabix Technologies Inc
0.32 €
(33.33%)
250
E3TMetavista 3D Inc
1.49 €
(-50.99%)
5.26M
E3O1Nexoptic Technology Corp
0.008 €
(-48.39%)
34.02k
POTAPortofino Resources Inc
0.0032 €
(-38.46%)
150k
G12Global Atomic Corp
0.425 €
(-31.95%)
729.18k
1UR1Bee Vectoring Technologies International Inc
0.0035 €
(-30.00%)
139.6k
PF8European Lithium Limited
0.0348 €
(-3.33%)
9.79M
E3TMetavista 3D Inc
1.49 €
(-50.99%)
5.26M
D7GNel ASA
0.1932 €
(0.99%)
4.13M
0QJHexagon Purus ASA
0.2725 €
(-22.59%)
3.99M
VAR1Varta AG
1.00 €
(37.93%)
3.62M

Discussion

View Full Feed
Louinjaxxx Louinjaxxx 5 minutes ago
It doesn't matter how a microcap was traded before coming under AXXA's wing..  AXXA will use their resources to make each profitable and a potential spinoff.  As such, the company does not report on the each subsideary...it's a holding company afterall.
AXXA
rogers711 rogers711 7 minutes ago
Where can you find this info at?
RDGL
zab zab 7 minutes ago
https://www.visaverge.com/news/trumps-costly-deportation-flights-852k-for-80-migrants/

Trump basically sent 1 million dollars to transport just 80 immigrants. Now let's do math, 1 million immigrants times 1 million dollars equals one trillion dollars. Maybe trump will try for 10 milli
Monksdream Monksdream 7 minutes ago
CVNA
https://investorshub.advfn.com/uimage/uploads/2025/1/25/gjhukIMG_4829.gif
CVNA
fuagf fuagf 8 minutes ago
LOL Phones are more like mosquitoes than a desktop, for sure. On desktop whatever is there basically stays while a phone move it slightly and wtf did that page go??? 'course my phone is still the one i was given some time ago and 3G so can only talk to someone on it on What'sApp. Still it's good fo
Hoskuld Hoskuld 9 minutes ago
A couple of semi-scientific financially motivated screwballs - Brodkin is one of them - have polluted the comments. The responses clearly refute their nonsense.
AVXL
Large Green Large Green 9 minutes ago
The UWs FOUGHT FOR THREE YEARS SO THEY COULD STAY IN CLASS 19 - IS THIS WHY SO YOU DECIDE

Also do not forget about the DST playing a huge role in potential future distributions

MORE THAN likely the UWs know MORE about returns here than ANYBODY...PERIOD

T
COOP
zab zab 10 minutes ago
https://www.visaverge.com/news/trumps-costly-deportation-flights-852k-for-80-migrants/

Just think only 1 million dollars to transport 80 migrants, trump is about spend another 10 trillion dollars to transport. So if Trump transports 1 million immigrants that's 1 trillion dollars, and
Seminole Red Seminole Red 11 minutes ago
this a tough course Mick, all my guys are over par for today so far through 5 holes
02opida 02opida 12 minutes ago
...












Research time
StockItOut StockItOut 12 minutes ago
Oh no! It hasn't? Well... at least they got those two successful burn tests done. Wheh!
XERI
frrol frrol 12 minutes ago
Good article in the WSJ reviewing a book called "Doctored", which focuses on the alleged Cassava research fraud (no trial, and no admission of wrong-doing). Biotech is filled with risks and false claims; fraud is just one. Note that there are still Cassava pumpers claiming "the drug works, ignore th
AVXL
Seminole Red Seminole Red 13 minutes ago
that was a great run
janice shell janice shell 13 minutes ago
Yes. What was the point of his supposed indecision?
smoking guns smoking guns 13 minutes ago
snow, so the insults, name calling and personal bashing are ok with you ?
IQST
Monksdream Monksdream 14 minutes ago
EOSE
https://investorshub.advfn.com/uimage/uploads/2025/1/25/pzdpbIMG_4828.gif
EOSE
Seminole Red Seminole Red 15 minutes ago
love those big bench seats
ge11 ge11 15 minutes ago
https://www.visualcapitalist.com/how-many-new-mines-are-needed-for-the-energy-transition/
NB
Ely Ely 16 minutes ago
Hey stupid! Or dumb-dumb, which do you like better? I can use either.
Just wanted to give you a heads up on this, you might want to see if you can get in on this....

"House Oversight Committee Chair James Comer slammed House Judiciary Committee Ranking Member Jamie Raskin (D-MD

Your Recent History

Delayed Upgrade Clock